The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Antimicrobial resistance: a concise update
Open accessAbstract
Antimicrobial resistance (AMR) is a serious threat to global public health, with approximately 5 million deaths associated with bacterial AMR in 2019. Tackling AMR requires a multifaceted and cohesive approach that ranges from increased understanding of mechanisms and drivers at the individual and population levels, AMR surveillance, antimicrobial stewardship, improved infection prevention and control measures, and strengthened global policies and funding to development of novel antimicrobial therapeutic strategies. In this rapidly advancing field, this Review provides a concise update on AMR, encompassing epidemiology, evolution, underlying mechanisms (primarily those related to last-line or newer generation of antibiotics), infection prevention and control measures, access to antibiotics, antimicrobial stewardship, AMR surveillance, and emerging non-antibiotic therapeutic approaches. The Review also discusses the potential roles of artificial intelligence in addressing AMR, including antimicrobial susceptibility testing, AMR surveillance, antimicrobial stewardship, diagnosis, and antimicrobial drug discovery and development. This Review highlights the urgent need for addressing the global effects of AMR and for rapid advancement of relevant technology in this dynamic field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02724-0 · Cited by 16,316
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Global trends in antimicrobial use in food animals
Van Boeckel, T. P., Brower, C., Gilbert, M., Grenfell, B. T., Levin, S. A., Robinson, T. P., Teillant, A., & Laxminarayan, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503141112 · Cited by 3,973
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Mueller, A., Schäberle, T. F., Hughes, D. E., Epstein, S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Ikuta, K. S., Swetschinski, L. R., Robles Aguilar, G., Sharara, F., Mestrovic, T., Gray, A. P., Davis Weaver, N., Wool, E. E., Han, C., Gershberg Hayoon, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)02185-7 · Cited by 2,235
Antimicrobial host defence peptides: functions and clinical potential
Mookherjee, N., Anderson, M. A., Haagsman, H. P., & Davidson, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0058-8 · Cited by 1,502
Access to effective antimicrobials: a worldwide challenge
Laxminarayan, R., Matsoso, P., Pant, S., Brower, C., Røttingen, J.-A., Klugman, K., & Davies, S. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00474-2 · Cited by 1,465
Molecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398
Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage
Hendriksen, R. S., Munk, P., Njage, P., van Bunnik, B., McNally, L., Lukjancenko, O., Röder, T., Nieuwenhuijse, D., Pedersen, S. K., Kjeldgaard, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08853-3 · Cited by 1,199
The value of antimicrobial peptides in the age of resistance
Magana, M., Pushpanathan, M., Santos, A. L., Leanse, L., Fernandez, M., Ioannidis, A., Giulianotti, M. A., Apidianakis, Y., Bradfute, S., Ferguson, A. L., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30327-3 · Cited by 1,150
Self-citationExploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
Bikard, D., Euler, C. W., Jiang, W., Nussenzweig, P. M., Goldberg, G. W., Duportet, X., Fischetti, V. A., & Marraffini, L. A. (2014) · Nature Biotechnology · doi:10.1038/nbt.3043 · Cited by 986
Diagnostic accuracy of deep learning in medical imaging: a systematic review and meta-analysis
Aggarwal, R., Sounderajah, V., Martin, G., Ting, D. S. W., Karthikesalingam, A., King, D., Ashrafian, H., & Darzi, A. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00438-z · Cited by 946
Self-citationThe immunology of host defence peptides: beyond antimicrobial activity
Hancock, R. E. W., Haney, E. F., & Gill, E. E. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.29 · Cited by 945
Self-citationESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
Miller, W. R., & Arias, C. A. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01054-w · Cited by 862
Type IIA topoisomerase inhibition by a new class of antibacterial agents
Bax, B. D., Chan, P. F., Eggleston, D. S., Fosberry, A., Gentry, D. R., Gorrec, F., Giordano, I., Hann, M. M., Hennessy, A., Hibbs, M., et al. (2010) · Nature · doi:10.1038/nature09197 · Cited by 860
Novel antibody-antibiotic conjugate eliminates intracellular S. aureus
Lehar, S. M., Pillow, T., Xu, M., Staben, L., Kajihara, K. K., Vandlen, R., DePalatis, L., Raab, H., Hazenbos, W. L., Hiroshi Morisaki, J., et al. (2015) · Nature · doi:10.1038/nature16057 · Cited by 838
A century of the phage: past, present and future
Salmond, G. P. C., & Fineran, P. C. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3564 · Cited by 823
Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases
Citorik, R. J., Mimee, M., & Lu, T. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.3011 · Cited by 808
Reducing antimicrobial use in food animals
Van Boeckel, T. P., Glennon, E. E., Chen, D., Gilbert, M., Robinson, T. P., Grenfell, B. T., Levin, S. A., Bonhoeffer, S., & Laxminarayan, R. (2017) · Science · doi:10.1126/science.aao1495 · Cited by 807
Global trends in antimicrobial use in food-producing animals: 2020 to 2030
Mulchandani, R., Wang, Y., Gilbert, M., & Boeckel, T. P. V. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001305 · Cited by 534
The role of vaccines in combatting antimicrobial resistance
Micoli, F., Bagnoli, F., Rappuoli, R., & Serruto, D. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00506-3 · Cited by 500
Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli
Sun, J., Chen, C., Cui, C.-Y., Zhang, Y., Liu, X., Cui, Z.-H., Ma, X.-Y., Feng, Y., Fang, L.-X., Lian, X.-L., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0496-4 · Cited by 484
Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria
Yosef, I., Manor, M., Kiro, R., & Qimron, U. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500107112 · Cited by 483
The scope of the antimicrobial resistance challenge
Okeke, I. N., de Kraker, M. E. A., Van Boeckel, T. P., Kumar, C. K., Schmitt, H., Gales, A. C., Bertagnolio, S., Sharland, M., & Laxminarayan, R. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00876-6 · Cited by 474
Pirnay, J.-P., Djebara, S., Steurs, G., Griselain, J., Cochez, C., De Soir, S., Glonti, T., Spiessens, A., Vanden Berghe, E., Green, S., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01705-x · Cited by 474
Magnano San Lio, R., Favara, G., Maugeri, A., Barchitta, M., & Agodi, A. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20031681 · Cited by 440
Discovery of antimicrobial peptides in the global microbiome with machine learning
Santos-Júnior, C. D., Torres, M. D. T., Duan, Y., Rodríguez del Río, Á., Schmidt, T. S. B., Chong, H., Fullam, A., Kuhn, M., Zhu, C., Houseman, A., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.013 · Cited by 419
Self-citationSafety and efficacy of phage therapy in difficult-to-treat infections: a systematic review
Uyttebroek, S., Chen, B., Onsea, J., Ruythooren, F., Debaveye, Y., Devolder, D., Spriet, I., Depypere, M., Wagemans, J., Lavigne, R., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00612-5 · Cited by 411
DRAMP 2.0, an updated data repository of antimicrobial peptides
Kang, X., Dong, F., Shi, C., Liu, S., Sun, J., Chen, J., Li, H., Xu, H., Lao, X., & Zheng, H. (2019) · Scientific Data · doi:10.1038/s41597-019-0154-y · Cited by 393
Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides
Lázár, V., Martins, A., Spohn, R., Daruka, L., Grézal, G., Fekete, G., Számel, M., Jangir, P. K., Kintses, B., Csörgő, B., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0164-0 · Cited by 375
Self-citationWang, M., Earley, M., Chen, L., Hanson, B. M., Yu, Y., Liu, Z., Salcedo, S., Cober, E., Li, L., Kanj, S. S., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00399-6 · Cited by 363
Cherkasov, A., Hilpert, K., Jenssen, H., Fjell, C. D., Waldbrook, M., Mullaly, S. C., Volkmer, R., & Hancock, R. E. W. (2009) · ACS Chemical Biology · doi:10.1021/cb800240j · Cited by 357
Self-citationDeep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii
Liu, G., Catacutan, D. B., Rathod, K., Swanson, K., Jin, W., Mohammed, J. C., Chiappino-Pepe, A., Syed, S. A., Fragis, M., Rachwalski, K., et al. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01349-8 · Cited by 351
Global geographic trends in antimicrobial resistance: the role of international travel
Frost, I., Van Boeckel, T. P., Pires, J., Craig, J., & Laxminarayan, R. (2019) · Journal of Travel Medicine · doi:10.1093/jtm/taz036 · Cited by 338
Reyes, J., Komarow, L., Chen, L., Ge, L., Hanson, B. M., Cober, E., Herc, E., Alenazi, T., Kaye, K. S., Garcia-Diaz, J., et al. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(22)00329-9 · Cited by 321
Kaye, K. S., Shorr, A. F., Wunderink, R. G., Du, B., Poirier, G. E., Rana, K., Miller, A., Lewis, D., O'Donnell, J., Chen, L., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00184-6 · Cited by 315
A novel antibiotic class targeting the lipopolysaccharide transporter
Zampaloni, C., Mattei, P., Bleicher, K., Winther, L., Thäte, C., Bucher, C., Adam, J.-M., Alanine, A., Amrein, K. E., Baidin, V., et al. (2024) · Nature · doi:10.1038/s41586-023-06873-0 · Cited by 308
Leveraging artificial intelligence in the fight against infectious diseases
Wong, F., de la Fuente-Nunez, C., & Collins, J. J. (2023) · Science · doi:10.1126/science.adh1114 · Cited by 301
Self-citationDurand-Réville, T. F., Guler, S., Comita-Prevoir, J., Chen, B., Bifulco, N., Huynh, H., Lahiri, S., Shapiro, A. B., McLeod, S. M., Carter, N. M., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.104 · Cited by 285
Emergence of methicillin resistance predates the clinical use of antibiotics
Larsen, J., Raisen, C. L., Ba, X., Sadgrove, N. J., Padilla-González, G. F., Simmonds, M. S. J., Loncaric, I., Kerschner, H., Apfalter, P., Hartl, R., et al. (2022) · Nature · doi:10.1038/s41586-021-04265-w · Cited by 285
Self-citationPorto, W. F., Irazazabal, L., Alves, E. S. F., Ribeiro, S. M., Matos, C. O., Pires, Á. S., Fensterseifer, I. C. M., Miranda, V. J., Haney, E. F., Humblot, V., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03746-3 · Cited by 284
Self-citationMachine learning for antimicrobial peptide identification and design
Wan, F., Wong, F., Collins, J. J., & de la Fuente-Nunez, C. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00152-x · Cited by 273
Self-citationAntibiofilm activity of host defence peptides: complexity provides opportunities
Hancock, R. E. W., Alford, M. A., & Haney, E. F. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00585-w · Cited by 270
Self-citationGlobal Burden of Colistin-Resistant Bacteria: Mobilized Colistin Resistance Genes Study (1980–2018)
Elbediwi, M., Li, Y., Paudyal, N., Pan, H., Li, X., Xie, S., Rajkovic, A., Feng, Y., Fang, W., C. Rankin, S., et al. (2019) · Microorganisms · doi:10.3390/microorganisms7100461 · Cited by 257
Antibiotic failure: Beyond antimicrobial resistance
de la Fuente-Nunez, C., Cesaro, A., & Hancock, R. E. W. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101012 · Cited by 254
Self-citationNick, J. A., Dedrick, R. M., Gray, A. L., Vladar, E. K., Smith, B. E., Freeman, K. G., Malcolm, K. C., Epperson, L. E., Hasan, N. A., Hendrix, J., et al. (2022) · Cell · doi:10.1016/j.cell.2022.04.024 · Cited by 251
Lewnard, J. A., Charani, E., Gleason, A., Hsu, L. Y., Khan, W. A., Karkey, A., Chandler, C. I. R., Mashe, T., Khan, E. A., Bulabula, A. N. H., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00862-6 · Cited by 220
Impact of existing vaccines in reducing antibiotic resistance: Primary and secondary effects
Klugman, K. P., & Black, S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721095115 · Cited by 218
Synthetic antibiofilm peptides
de la Fuente-Núñez, C., Cardoso, M. H., de Souza Cândido, E., Franco, O. L., & Hancock, R. E. W. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.12.015 · Cited by 214
Self-citationPletzer, D., Mansour, S. C., & Hancock, R. E. W. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007084 · Cited by 211
Self-citationKariyawasam, R. M., Julien, D. A., Jelinski, D. C., Larose, S. L., Rennert-May, E., Conly, J. M., Dingle, T. C., Chen, J. Z., Tyrrell, G. J., Ronksley, P. E., et al. (2022) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-022-01085-z · Cited by 210
Gerding, D. N., Kelly, C. P., Rahav, G., Lee, C., Dubberke, E. R., Kumar, P. N., Yacyshyn, B., Kao, D., Eves, K., Ellison, M. C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy171 · Cited by 204
Day, M. J., Hopkins, K. L., Wareham, D. W., Toleman, M. A., Elviss, N., Randall, L., Teale, C., Cleary, P., Wiuff, C., Doumith, M., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30273-7 · Cited by 200
Global Epidemiology and Mechanisms of Resistance of Acinetobacter baumannii-calcoaceticus Complex
Castanheira, M., Mendes, R. E., & Gales, A. C. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad109 · Cited by 197
Mining for encrypted peptide antibiotics in the human proteome
Torres, M. D. T., Melo, M. C. R., Flowers, L., Crescenzi, O., Notomista, E., & de la Fuente-Nunez, C. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00801-1 · Cited by 194
Self-citationDeep-learning-enabled antibiotic discovery through molecular de-extinction
Wan, F., Torres, M. D. T., Peng, J., & de la Fuente-Nunez, C. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01201-x · Cited by 189
Self-citationEl Haddad, L., Harb, C. P., Gebara, M. A., Stibich, M. A., & Chemaly, R. F. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy947 · Cited by 185
Generative AI for designing and validating easily synthesizable and structurally novel antibiotics
Swanson, K., Liu, G., Catacutan, D. B., Arnold, A., Zou, J., & Stokes, J. M. (2024) · Nature Machine Intelligence · doi:10.1038/s42256-024-00809-7 · Cited by 184
Molecular de-extinction of ancient antimicrobial peptides enabled by machine learning
Maasch, J. R. M. A., Torres, M. D. T., Melo, M. C. R., & de la Fuente‐Núñez, C. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.07.001 · Cited by 180
Borin, J. M., Avrani, S., Barrick, J. E., Petrie, K. L., & Meyer, J. R. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2104592118 · Cited by 178
Permeability barriers of Gram‐negative pathogens
Zgurskaya, H. I., & Rybenkov, V. V. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14134 · Cited by 175
Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children
Garegnani, L., Styrmisdóttir, L., Roson Rodriguez, P., Escobar Liquitay, C. M., Esteban, I., & Franco, J. V. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013757.pub2 · Cited by 168
Plasmid-mediated colistin-resistance genes: mcr
Liu, J.-H., Liu, Y.-Y., Shen, Y.-B., Yang, J., Walsh, T. R., Wang, Y., & Shen, J. (2024) · Trends in Microbiology · doi:10.1016/j.tim.2023.10.006 · Cited by 167
Maki, G., & Zervos, M. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.04.014 · Cited by 163
Monoclonal Antibodies as an Antibacterial Approach Against Bacterial Pathogens
Zurawski, D. V., & McLendon, M. K. (2020) · Antibiotics · doi:10.3390/antibiotics9040155 · Cited by 154
Thorpe, H. A., Booton, R. D., Kallonen, T., Gibbon, M. J., Couto, N., Passet, V., López-Fernández, S., Rodrigues, C., Matthews, L., Mitchell, S., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01263-0 · Cited by 147
Efficient inter-species conjugative transfer of a CRISPR nuclease for targeted bacterial killing
Hamilton, T. A., Pellegrino, G. M., Therrien, J. A., Ham, D. T., Bartlett, P. C., Karas, B. J., Gloor, G. B., & Edgell, D. R. (2019) · Nature Communications · doi:10.1038/s41467-019-12448-3 · Cited by 146
Yang, L., Shen, Y., Jiang, J., Wang, X., Shao, D., Lam, M. M. C., Holt, K. E., Shao, B., Wu, C., Shen, J., et al. (2022) · Nature Food · doi:10.1038/s43016-022-00470-6 · Cited by 145
Mendelson, M., Lewnard, J. A., Sharland, M., Cook, A., Pouwels, K. B., Alimi, Y. H., Mpundu, M. M., Wesangula, E., Weese, J. S., Røttingen, J., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01019-5 · Cited by 126
Argimón, S., Masim, M., Gayeta, J. M., Lagrada, M. L., Macaranas, P. K. V., Cohen, V., Limas, M. T., Espiritu, H. G., Palarca, J. C., Chilam, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16322-5 · Cited by 123
François, B., Jafri, H. S., Chastre, J. E., García, M. S., Eggimann, P., Dequin, P., Huberlant, V., Soria, L. V., Boulain, T., Bretonnière, C., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30995-6 · Cited by 121
Li, J., Zhou, P., Wang, J., Li, H., Xu, H., Meng, Y., Ye, F., Tan, Y., Gong, Y., & Yin, X. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00130-5 · Cited by 117
Unrealized targets in the discovery of antibiotics for Gram-negative bacterial infections
Theuretzbacher, U., Blasco, B., Duffey, M., & Piddock, L. J. V. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00791-6 · Cited by 115
Strategies in Translating the Therapeutic Potentials of Host Defense Peptides
Ting, D. S. J., Beuerman, R. W., Dua, H. S., Lakshminarayanan, R., & Mohammed, I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00983 · Cited by 113
Self-citationDefining new chemical space for drug penetration into Gram-negative bacteria
Zhao, S., Adamiak, J. W., Bonifay, V., Mehla, J., Zgurskaya, H. I., & Tan, D. S. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-00674-6 · Cited by 112
Laxminarayan, R., Impalli, I., Rangarajan, R., Cohn, J., Ramjeet, K., Trainor, B. W., Strathdee, S., Sumpradit, N., Berman, D., Wertheim, H., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00878-x · Cited by 111
Kanjilal, S., Oberst, M., Boominathan, S., Zhou, H. H., Hooper, D. C., & Sontag, D. A. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay5067 · Cited by 102
Liu, M., Hernandez-Morales, A., Clark, J., Le, T., Biswas, B., Bishop‐Lilly, K. A., Henry, M., Quinones, J., Voegtly, L. J., Cer, R. Z., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31455-5 · Cited by 102
Shi, Z., Zhang, J., Tian, L., Xin, L., Liang, C., Ren, X., & Li, M. (2023) · Molecules · doi:10.3390/molecules28041762 · Cited by 100
Wee, B. A., Muloi, D. M., & van Bunnik, B. A. D. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.09.019 · Cited by 89
Lin, L. K., Sun, R., Yao, T., Zhou, X., & Harbarth, S. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2020-003599 · Cited by 80
The Use of Antibody-Antibiotic Conjugates to Fight Bacterial Infections
Cavaco, M. C., Castanho, M. A. R. B., & Neves, V. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.835677 · Cited by 75
Advanced delivery systems for peptide antibiotics
Cesaro, A., Lin, S., Pardi, N., & de la Fuente‐Núñez, C. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114733 · Cited by 75
Nsubuga, M., Galiwango, R. M., Jjingo, D., & Mboowa, G. (2024) · BMC Genomics · doi:10.1186/s12864-024-10214-4 · Cited by 68
Assessing the global risk of typhoid outbreaks caused by extensively drug resistant Salmonella Typhi
Walker, J. W., Chaguza, C., Grubaugh, N. D., Carey, M. E., Baker, S. G., Khan, K., Bogoch, I. I., & Pitzer, V. E. (2023) · Nature Communications · doi:10.1038/s41467-023-42353-9 · Cited by 67
Sturm, A., Jóźwiak, G., Verge, M. P., Munch, L., Cathomen, G., Vocat, A., Luraschi, A., Orlando, C., Fromm, K., Delarze, E., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46213-y · Cited by 66
Szili, P. É., Draskovits, G., Revesz, T., Bogár, F., Balogh, D., Martinek, T. A., Daruka, L., Spohn, R., Vásárhelyi, B. M., Czikkely, M. S., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00207-19 · Cited by 65
Self-citationReversal of mcr-1-Mediated Colistin Resistance in Escherichia coli by CRISPR-Cas9 System
Wan, P., Cui, S., Ma, Z.-B., Chen, L., Li, X., Zhao, R., Xiong, W., & Zeng, Z. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s244885 · Cited by 59
Coll, F., Gouliouris, T., Blane, B., Yeats, C., Raven, K. E., Ludden, C., Khokhar, F., Wilson, H. J., Roberts, L. W., Harrison, E. M., et al. (2024) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00297-5 · Cited by 55
Self-citationTang, B., Yang, A., Liu, P., Wang, Z., Jian, Z., Chen, X., Yan, Q., Liang, X., & Liu, W. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01444-22 · Cited by 53
DeNegre, A. A., Ndeffo-Mbah, M. L., Myers, K., & Fefferman, N. H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212969 · Cited by 50
Zhang, X., Qian, C., Tang, M., Zeng, W., Kong, J., Fu, C., Xu, C., Ye, J., & Zhou, T. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100952 · Cited by 47
An integrated nationwide genomics study reveals transmission modes of typhoid fever in China
Feng, Y., Pan, H., Zheng, B., Li, F., Teng, L., Jiang, Z., Feng, M., Zhou, X., Peng, X., Xu, X., et al. (2023) · mBio · doi:10.1128/mbio.01333-23 · Cited by 47
Elad, S., Epstein, J. B., Raber‐Durlacher, J. E., Donnelly, P., & Strahilevitz, J. (2011) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2011.01094.x · Cited by 45
Paving the way for precise diagnostics of antimicrobial resistant bacteria
Wang, H., Jia, C., Li, H., Yin, R., Chen, J., Li, Y., & Yue, M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.976705 · Cited by 45
Antibacterial agents active against Gram Negative Bacilli in phase I, II, or III clinical trials
Paterson, D. L. (2024) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2024.2326028 · Cited by 44
Apjok, G., Számel, M., Christodoulou, C., Seregi, V., Vásárhelyi, B. M., Stirling, T., Eszenyi, B., Sári, T., Vidovics, F., Nagrand, E., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01320-2 · Cited by 35
Self-citationAntimicrobial Resistance in the Tropics
Semret, M., & Haraoui, L. (2019) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2018.10.009 · Cited by 33
Poku, E. N., Cooper, K. L., Cantrell, A. J., Harnan, S., Sin, M. A., Zanuzdana, A., & Hoffmann, A. (2022) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlad001 · Cited by 32
Ting, D. S. J., Goh, E. T. L., Mayandi, V., Busoy, J. M. F., Aung, T. T., Periayah, M. H., Nubile, M., Mastropasqua, L., Said, D. G., Htoon, H. M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-97821-3 · Cited by 29
Self-citationKrein support vector machine classification of antimicrobial peptides
Redshaw, J., Ting, D. S. J., Brown, A., Hirst, J. D., & Gärtner, T. (2023) · Digital Discovery · doi:10.1039/d3dd00004d · Cited by 29
Self-citationTing, D. S. J., Li, J., Verma, C. S., Goh, E. T. L., Nubile, M., Mastropasqua, L., Said, D. G., Beuerman, R. W., Lakshminarayanan, R., Mohammed, I., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.731499 · Cited by 24
Self-citationHuman gut metagenomic mining reveals an untapped source of peptide antibioticsPreprint
Torres, M. D. T., Brooks, E. F., Cesaro, A., Sberro, H., Nicolaou, C., Bhatt, A. S., & de la Fuente‐Núñez, C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.31.555711 · Cited by 12
Metadata
- Authors
- Ho, C. S., Wong, C. T. H., Aung, T. T., Lakshminarayanan, R., Mehta, J. S., Rauz, S., McNally, A., Kintses, B., Peacock, S. J., de la Fuente-Nunez, C., Hancock, R. E. W., & Ting, D. S. J.
- Venue
- The Lancet Microbe
- Publisher
- Elsevier BV
- Published
- 2025-01
- Volume
- 6
- Issue
- 1
- Pages
- 100947
- ISSN
- 2666-5247 (ISSN-L)
- OpenAlex
- W4402655854
- Cited by
- 634
- References
- 103
- FWCI
- 121.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.